168 HIGH RATES OF UNDETECTABLE HCVRNA IN LIVER TRANSPLANT RECIPIENTS TREATED WITH PROTEASE INHIBITOR-BASED ANTIVIRAL THERAPY FOR RECURRENT HEPATITIS C | Publicación